Avricore Health Inc. (AVCR.V)
| Previous Close | 0.2050 |
| Open | 0.1950 |
| Bid | 0.2100 x 0 |
| Ask | 0.2250 x 0 |
| Day's Range | 0.2100 - 0.2250 |
| 52 Week Range | 0.1050 - 0.3350 |
| Volume | |
| Avg. Volume | 244,569 |
| Market Cap | 21.976M |
| Beta (5Y Monthly) | -1.79 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- GlobeNewswire
Avricore Grants Options
VANCOUVER, British Columbia, Aug. 30, 2024 (GLOBE NEWSWIRE) -- AVRICORE HEALTH INC. (TSXV: AVCR) (the "Company" or “Avricore”) today announces that the Company’s board of directors has approved the granting of stock options (the “Options”) exercisable for a total of 3,361,000 common shares to its directors, officers, employees and consultants at an exercise price of CAD $0.29 per common share. All Options were granted pursuant to the Company’s stock option plan and are subject to the terms of th
- GlobeNewswire
Avricore Health Corporate Update: Mid-Year Results Show Strong Growth, Profitability
VANCOUVER, British Columbia, Aug. 29, 2024 (GLOBE NEWSWIRE) -- AVRICORE HEALTH INC. (TSXV: AVCR) (the "Company" or “Avricore”) reports on its mid-year results for 2024 demonstrating the Company’s continued success in maintaining strong growth in revenues while achieving net profitability. In the six months ended June 30, 2024 revenues grew by 84% year-over-year, topping $2,169,513 with gross profit increasing 94% equalling $855,566. This was supported by Q2 2024 revenue increasing 91% against th
- GlobeNewswire
AVRICORE HEALTH CORPORATE UPDATE – COMPANY ACHIEVES PROFITABILITY
VANCOUVER, British Columbia, June 03, 2024 (GLOBE NEWSWIRE) -- AVRICORE HEALTH INC. (TSXV: AVCR) (the "Company" or “Avricore”) reports on results for the first three months of 2024, the first period of net profitability for the Company. The Company realized a comprehensive income of $168,537 for the three months ended March 31, 2024 (2023 - loss $191,512) and a net increase in cash of $307,470, demonstrating the Company’s commitment to growth while managing operational efficiencies. “HealthTab™’
